1. Home
  2. PLUR
  3. PLUR News

Latest Pluri Inc. (PLUR) News on July 6, 2025

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
PLUR

GOBankingRates

a month ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone
PLUR

GOBankingRates

a month ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
PLUR

GOBankingRates

a month ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true
PLUR

Yahoo Finance

a month ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right
PLUR

The Guardian

a month ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF
PLUR

Yahoo Finance Video

a month ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
PLUR

Benzinga

a month ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says
PLUR

Reuters

a month ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion
PLUR

GlobeNewswire

2 months ago

Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion

PLUR

Associated Press Finance

2 months ago

Pluri: Fiscal Q3 Earnings Snapshot

Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.
PLUR

GlobeNewswire

2 months ago

Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd.

Pluri’s immune cell expansion technologies gain patents
PLUR

Pharmaceutical Technology

3 months ago

Pluri’s immune cell expansion technologies gain patents

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel
PLUR

GlobeNewswire

3 months ago

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel

PLUR

MT Newswires

4 months ago

Pluri, Hemafund Sign Exclusive Collaboration Deal on Potential Radiation Treatment; Shares Rise

Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness
PLUR

GlobeNewswire

4 months ago

Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness

Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution
PLUR

GlobeNewswire

5 months ago

Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution

PLUR

Associated Press Finance

5 months ago

Pluri: Fiscal Q2 Earnings Snapshot

Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million
PLUR

GlobeNewswire

5 months ago

Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million

Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market
PLUR

TipRanks

5 months ago

Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market

Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition
PLUR

GlobeNewswire

5 months ago

Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition

Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
PLUR

GlobeNewswire

7 months ago

Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease

Pluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025
PLUR

GlobeNewswire

7 months ago

Pluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
PLUR

ACCESSWIRE

7 months ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns
PLUR

GlobeNewswire

7 months ago

Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns

Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)
PLUR

Simply Wall St.

8 months ago

Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)

PLUR

Associated Press Finance

8 months ago

Pluri: Fiscal Q1 Earnings Snapshot

PLUR

ACCESSWIRE

8 months ago

Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing
PLUR

PR Newswire

8 months ago

BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority
PLUR

GlobeNewswire

8 months ago

Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
PLUR

ACCESSWIRE

10 months ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

PLUR

MT Newswires

a year ago

Pluri Shares Rise After Manufacturing Accord With Kadimastem Set

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
PLUR

GlobeNewswire

a year ago

Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply
PLUR

GlobeNewswire

a year ago

Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply

PLUR

MT Newswires

a year ago

Pluri Appoints Liat Zalts as CFO

PLUR

MT Newswires

a year ago

Sector Update: Consumer

PLUR

MT Newswires

a year ago

Pluri's Ever After Foods Subsidiary Gets $10 Million Investment; Shares Rise

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
PLUR

GlobeNewswire

a year ago

Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
PLUR

GlobeNewswire

a year ago

U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
PLUR

GlobeNewswire

a year ago

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)
PLUR

Simply Wall St.

a year ago

Pluri Third Quarter 2024 Earnings: US$1.01 loss per share (vs US$1.53 loss in 3Q 2023)

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
PLUR

GlobeNewswire

a year ago

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method
PLUR

GlobeNewswire

a year ago

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
PLUR

GlobeNewswire

a year ago

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

Pluri Inc. Announces 1-for-8 Reverse Share Split
PLUR

GlobeNewswire

a year ago

Pluri Inc. Announces 1-for-8 Reverse Share Split

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report
PLUR

GlobeNewswire

a year ago

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

Engage with Pluri's Talent: Exciting Conference Appearances Ahead
PLUR

GlobeNewswire

a year ago

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
PLUR

GlobeNewswire

a year ago

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
PLUR

GlobeNewswire

a year ago

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board
PLUR

GlobeNewswire

a year ago

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals
PLUR

GlobeNewswire

a year ago

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)
PLUR

Simply Wall St.

a year ago

Pluri Second Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.24 loss in 2Q 2023)

PLUR

Associated Press Finance

a year ago

Pluri: Fiscal Q2 Earnings Snapshot

Third Coast Bancshares, Inc. (NASDAQ:TCBX) Q4 2023 Earnings Call Transcript
PLUR

Insider Monkey

a year ago

Third Coast Bancshares, Inc. (NASDAQ:TCBX) Q4 2023 Earnings Call Transcript

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis
PLUR

GlobeNewswire

a year ago

Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

Gilead Sciences, Citi, Digital World Acquisition: Top Stocks
PLUR

Yahoo Finance Video

a year ago

Gilead Sciences, Citi, Digital World Acquisition: Top Stocks

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
PLUR

GlobeNewswire

a year ago

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
PLUR

GlobeNewswire

a year ago

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY FOURTH QUARTER 2023 RESULTS
PLUR

PR Newswire

a year ago

ASHFORD HOSPITALITY TRUST ANNOUNCES PRELIMINARY FOURTH QUARTER 2023 RESULTS

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization
PLUR

GlobeNewswire

a year ago

Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions
PLUR

Business Wire

2 years ago

Tiptree Inc. Announces Tax Treatment of 2023 Common Stock Distributions

Resources Connection, Inc. (NASDAQ:RGP) Q2 2024 Earnings Call Transcript
PLUR

Insider Monkey

2 years ago

Resources Connection, Inc. (NASDAQ:RGP) Q2 2024 Earnings Call Transcript

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns
PLUR

PR Newswire

2 years ago

AdTheorent Partners with Jounce Media to Verify Removal of Made for Advertising (MFA) Properties from Its Campaigns

Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction
PLUR

GlobeNewswire

2 years ago

Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

Reorganization of Virtus Stone Harbor Closed-End Funds Completed
PLUR

Business Wire

2 years ago

Reorganization of Virtus Stone Harbor Closed-End Funds Completed

Zentek and 1Click Heating and Cooling Sign Distribution Agreement
PLUR

ACCESSWIRE

2 years ago

Zentek and 1Click Heating and Cooling Sign Distribution Agreement

Fathom Realty to raise agent fees in 2024 to boost earnings
PLUR

HousingWire

2 years ago

Fathom Realty to raise agent fees in 2024 to boost earnings

Sidoti Events, LLC's Virtual December Small-Cap Conference
PLUR

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

UCloudlink Group Inc. Sponsored ADR (UCL) Beats Q3 Earnings and Revenue Estimates
PLUR

Zacks

2 years ago

UCloudlink Group Inc. Sponsored ADR (UCL) Beats Q3 Earnings and Revenue Estimates

PLUR

GlobeNewswire

2 years ago

UCLOUDLINK GROUP INC. Announces Unaudited Third Quarter 2023 Financial Results

PLUR

Associated Press Finance

2 years ago

Pluri: Fiscal Q1 Earnings Snapshot

MISTRAS Group to Participate in Sidoti Micro Cap Virtual Conference on November 15-16, 2023
PLUR

GlobeNewswire

2 years ago

MISTRAS Group to Participate in Sidoti Micro Cap Virtual Conference on November 15-16, 2023

PLUR

GlobeNewswire

2 years ago

UCLOUDLINK GROUP INC. to Report Third Quarter 2023 Financial Results on November 15, 2023

The one-year earnings decline is not helping Big 5 Sporting Goods' (NASDAQ:BGFV share price, as stock falls another 25% in past week
PLUR

Simply Wall St.

2 years ago

The one-year earnings decline is not helping Big 5 Sporting Goods' (NASDAQ:BGFV share price, as stock falls another 25% in past week

Share on Social Networks: